Radcliffe Capital Management’s GP-Act III Acquisition Corp GPAT Stock Holding History
Bought
Maintained
Sold
Other funds holding GPAT
PAMP
AA
MI
AIMCA
MSU
WRBC
HIM
Radcliffe Capital Management's GPAT Position: Q2 2026 in Review
Radcliffe Capital Management sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 623,267 shares — an estimated $6.76M sold.
Radcliffe Capital Management first reported a position in GPAT in Q2 2025 and held it in 4 quarters. The position peaked at $6.76M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.
- Radcliffe Capital Management reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
- Radcliffe Capital Management sold 623,267 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $6.76M.
- Radcliffe Capital Management first reported a position in GP-Act III Acquisition Corp in Q2 2025 and held it in 4 quarters.
- Radcliffe Capital Management's GP-Act III Acquisition Corp position peaked at $6.76M in Q1 2026.
- 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.
Based on Radcliffe Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.